On the other hand, RAS-blocking agents, such as angiotensin converting enzyme (ACE) inhibitors and AT1 receptor blockers (ARBs), have been shown to be effective in the management of hypertension-related cardiovascular diseases and end-organ damage [5]. Here, ACE is linked to Hypertension.